HF2047

Enrollee required to receive any rebates and discounts accrued directly or indirectly to health carriers.
Legislative Session 94 (2025-2026)

Related bill: SF2176

AI Generated Summary

Purpose of the Bill

The purpose of this bill is to regulate how rebates and discounts from pharmaceutical manufacturers are applied to prescription drug pricing, ensuring that these benefits are passed on to the enrollees at the point of sale in Minnesota. This aims to lower out-of-pocket costs for consumers when purchasing prescription drugs.

Main Provisions

  • Cost-Sharing Reductions: The bill mandates that any rebates or discounts on prescription drugs must be directly credited to the enrollee's cost-sharing obligations (like deductibles or coinsurance) at the point of sale. This means that when someone buys a prescription drug, the price will be reduced by the total amount of rebates received for that drug.

  • Definition of Terms: It provides definitions for terms such as "defined cost-sharing," "health carrier," "price protection rebate," and "rebate," to clarify how these terms are applied within the legislation.

  • Confidentiality of Rebate Information: The bill includes strict confidentiality requirements regarding rebate information. This information is considered a trade secret and must not be publicly disclosed in a way that reveals specific details about products or manufacturers.

Significant Changes to Existing Law

  • Transparency and Savings: The bill requires transparency in how rebates and discounts affect the cost of prescription drugs for consumers, ensuring they are used to reduce the cost for the buyer at the point of sale.

  • Regulations on Rebate Disclosure: It establishes new confidentiality rules surrounding the disclosure of rebate information, highlighting its sensitive nature and protecting it as a trade secret.

  • Enforcement and Penalties: The bill enforces compliance by allowing penalties such as civil fines or license suspension for health carriers or pharmacy benefit managers that fail to adhere to these new rules.

Relevant Terms

  • Cost-Sharing
  • Rebates and Discounts
  • Prescription Drugs
  • Health Carrier
  • Pharmacy Benefit Manager
  • Confidentiality
  • Price Protection Rebate
  • Trade Secret

Bill text versions

Showing the most recent version. There are  2  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
March 10, 2025HouseActionIntroduction and first reading, referred toCommerce Finance and Policy
Showing the 5  most recent stages. This bill has 1  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…